Concepedia

Hamid Sayar

HS

16

Publications

1.4K

Citations

13

H-Index

2004

Active since

Affiliations

Indiana University – Purdue University Indianapolis(Current)

The University of Texas MD Anderson Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Cornell University

Monash University

Hamid Sayar is an author at Indiana University – Purdue University Indianapolis specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2004–2025

16

Publications

16

Where West Meets East: The Complex mtDNA Landscape of the Southwest and Central Asian Corridor

Lluís Quintana‐Murci, Raphaëlle Chaix, R. Spencer Wells et al. · The American Journal of Human Genetics · 2004 · 422 citations · Full text

, , +9

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · New England Journal of Medicine · 2020 · 403 citations · Full text

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

Farhad Ravandi, Ellen K. Ritchie, Hamid Sayar et al. · The Lancet Oncology · 2015 · 153 citations · Full text

, , +8

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · Blood · 2019 · 97 citations

Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study

Guillermo Garcia‐Manero, Yasmin Abaza, Koichi Takahashi et al. · Blood Advances · 2019 · 86 citations · Full text

Rows per page

1–5 of 16